BioNTech
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Germany · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
An Der Goldgrube 12, Mainz, Rheinland-Pf...Phone Number
+49613190840Website
www.biontech.comRevenue
$3.2 BillionStock Symbol
BNTXIndustry
ZI Rank: 17
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
18
16
33
27
25
17
About BioNTech
BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseasesExplore more
BioNTech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioNTech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
BioNTech, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if BioNTech is spiking on competitors!
Funding: Get notified immidiatlly once BioNTech has new funding data
Click to see if BioNTech had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at BioNTech
Product Launch: Get notified when BioNTech launches new products
Check if BioNTech has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on BioNTech recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
BioNTech financials insights
Gather financial insights about BioNTech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$270M
2019
Series B
$325M
Other Financing Round
$55.7M
2020
Multiple Rounds
$694.8M
BioNTech Tech Stack
A closer look at the technologies used by BioNTech
See more technologies
Most Recent Scoops
Open Position
Open Position
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Person-Based
Product Launch
BioNTech News & Media
BioNTech’s oncology pivot comes with a new CEO
Guido Oelkers will inherit a deep cancer pipeline, declining vaccine sales and $19 billion to fund the transition.Pfizer Inc. (PFE) vs. BioNTech SE (BNTX): Which Pharma Giant Is Better Positioned for the Post-COVID Era?
Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX), two companies forever linked by their historic COVID-19 vaccine partnership, reported Q2 2026 earnings alongside major strategic announcements. While the European Commission authorized their updated XFG-adapted COVID-19 vaccine on July 29, the two partners are traveling down very different paths. One is leveraging massive scale and aggressive cost-cutting […]BioNTech Q2 Earnings Call Highlights
BioNTech (NASDAQ:BNTX) reported second-quarter 2026 revenue of €106 million, down from €261 million a year earlier, as lower U.S. demand for its COVID-19 vaccine weighed on results. The prior-year quarter also benefited from a one-time compensation payment from Pfizer related to its decision to optBioNTech Announces Second Quarter 2026 Financial Results and Corporate Update
Conference call and webcast scheduled for August 4, 2026, at 8:00 a.m. EDT (2:00 p.m. CEST)
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioNTech
Sign Up For FreeTo access detailed company insights
BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases... Read More
